US Stock MarketDetailed Quotes

FDMT 4D Molecular Therapeutics

Watchlist
  • 6.310
  • +0.530+9.17%
Close Dec 20 16:00 ET
  • 6.310
  • 0.0000.00%
Post 17:25 ET
291.70MMarket Cap-2.21P/E (TTM)

4D Molecular Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
57.01%501.89M
74.63%541.95M
162.36%525.91M
34.97%288.23M
34.97%288.23M
40.38%319.66M
28.73%310.34M
-15.12%200.45M
-13.81%213.55M
-13.81%213.55M
-Cash and cash equivalents
-31.97%187.54M
-19.99%189.06M
250.77%275.59M
375.84%249.11M
375.84%249.11M
154.56%275.68M
108.23%236.31M
3.42%78.57M
-65.78%52.35M
-65.78%52.35M
-Short-term investments
614.67%314.35M
376.67%352.89M
105.37%250.32M
-75.73%39.12M
-75.73%39.12M
-63.17%43.99M
-41.98%74.03M
-23.91%121.89M
70.09%161.2M
70.09%161.2M
Other current assets
3.33%8.87M
43.78%10.69M
46.95%9.68M
20.11%8.36M
20.11%8.36M
--8.58M
--7.43M
--6.59M
-17.73%6.96M
-17.73%6.96M
Total current assets
55.60%510.76M
73.91%552.63M
158.69%535.59M
34.50%296.59M
34.50%296.59M
41.19%328.24M
28.90%317.78M
-14.81%207.04M
-13.96%220.51M
-13.96%220.51M
Non current assets
Net PPE
27.35%41.63M
-12.48%29.45M
-10.88%30.58M
-10.42%31.67M
-10.42%31.67M
-7.95%32.69M
-3.64%33.65M
5.13%34.32M
22.08%35.35M
22.08%35.35M
-Gross PPE
31.25%57.12M
0.61%43.75M
1.43%43.69M
1.21%43.6M
1.21%43.6M
3.06%43.52M
5.76%43.48M
12.24%43.07M
25.66%43.08M
25.66%43.08M
-Accumulated depreciation
-43.02%-15.49M
-45.38%-14.3M
-49.68%-13.11M
-54.40%-11.93M
-54.40%-11.93M
-61.32%-10.83M
-58.72%-9.84M
-52.76%-8.76M
-45.13%-7.73M
-45.13%-7.73M
Investments and advances
--48.78M
--35.72M
4,379.86%62.94M
123.19%10.95M
123.19%10.95M
--0
--0
-97.09%1.41M
-92.75%4.91M
-92.75%4.91M
Other non current assets
319.94%2.86M
114.81%2.32M
-38.81%771K
-36.67%684K
-36.67%684K
-35.23%682K
12.15%1.08M
44.00%1.26M
79.40%1.08M
79.40%1.08M
Total non current assets
179.51%93.27M
94.33%67.48M
154.98%94.3M
4.76%43.3M
4.76%43.3M
-30.02%33.37M
-38.44%34.73M
-54.83%36.98M
-57.48%41.34M
-57.48%41.34M
Total assets
67.04%604.03M
75.92%620.12M
158.13%629.88M
29.81%339.89M
29.81%339.89M
29.07%361.61M
16.36%352.5M
-24.90%244.02M
-25.92%261.85M
-25.92%261.85M
Liabilities
Current liabilities
Payables
-37.96%2.92M
-1.77%3.43M
75.12%4.22M
5.81%3.52M
5.81%3.52M
218.45%4.71M
5.34%3.49M
-10.18%2.41M
-30.27%3.32M
-30.27%3.32M
-accounts payable
-37.96%2.92M
-1.77%3.43M
75.12%4.22M
5.81%3.52M
5.81%3.52M
218.45%4.71M
5.34%3.49M
-10.18%2.41M
-30.27%3.32M
-30.27%3.32M
Current accrued expenses
110.07%21.42M
94.25%12.78M
66.48%9.01M
35.45%12.01M
35.45%12.01M
40.72%10.19M
6.72%6.58M
2.85%5.41M
14.54%8.87M
14.54%8.87M
Current debt and capital lease obligation
62.86%5.09M
3.00%3.2M
18.48%3.17M
18.61%3.15M
18.61%3.15M
18.72%3.13M
19.53%3.1M
31.47%2.68M
115.68%2.66M
115.68%2.66M
-Current capital lease obligation
62.86%5.09M
3.00%3.2M
18.48%3.17M
18.61%3.15M
18.61%3.15M
18.72%3.13M
19.53%3.1M
31.47%2.68M
115.68%2.66M
115.68%2.66M
Current deferred liabilities
-73.08%35K
--0
--0
-69.12%273K
-69.12%273K
-94.11%130K
-74.47%576K
-63.11%778K
-65.99%884K
-65.99%884K
Current liabilities
62.23%29.47M
41.12%19.4M
45.44%16.4M
20.47%18.95M
20.47%18.95M
33.91%18.16M
-4.06%13.75M
-6.72%11.28M
-3.72%15.73M
-3.72%15.73M
Non current liabilities
Long term debt and capital lease obligation
64.10%19.74M
-16.50%10.46M
-15.43%11M
-14.46%11.52M
-14.46%11.52M
-13.56%12.03M
-13.02%12.53M
-12.02%13.01M
-11.49%13.47M
-11.49%13.47M
-Long term capital lease obligation
64.10%19.74M
-16.50%10.46M
-15.43%11M
-14.46%11.52M
-14.46%11.52M
-13.56%12.03M
-13.02%12.53M
-12.02%13.01M
-11.49%13.47M
-11.49%13.47M
Non current deferred liabilities
16.79%1.28M
55.61%1.32M
49.55%1.32M
-9.67%972K
-9.67%972K
9.49%1.1M
-41.67%847K
-49.80%884K
-56.80%1.08M
-56.80%1.08M
Derivative product liabilities
7.32%396K
80.19%382K
68.49%369K
74.06%369K
74.06%369K
73.24%369K
-4.50%212K
-0.90%219K
-0.93%212K
-0.93%212K
Other non current liabilities
880.00%196K
791.67%214K
696.55%231K
1,080.95%248K
1,080.95%248K
-13.04%20K
100.00%24K
93.33%29K
-82.50%21K
-82.50%21K
Total non current liabilities
59.92%21.62M
-9.08%12.37M
-8.61%12.92M
-11.28%13.11M
-11.28%13.11M
-10.82%13.52M
-15.40%13.61M
-15.75%14.14M
-18.09%14.78M
-18.09%14.78M
Total liabilities
61.24%51.08M
16.15%31.78M
15.38%29.32M
5.09%32.06M
5.09%32.06M
10.30%31.68M
-10.06%27.36M
-11.97%25.42M
-11.26%30.51M
-11.26%30.51M
Shareholders'equity
Share capital
25.00%5K
25.00%5K
66.67%5K
33.33%4K
33.33%4K
33.33%4K
33.33%4K
0.00%3K
0.00%3K
0.00%3K
-common stock
25.00%5K
25.00%5K
66.67%5K
33.33%4K
33.33%4K
33.33%4K
33.33%4K
0.00%3K
0.00%3K
0.00%3K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-37.46%-526.52M
-29.48%-482.68M
-30.47%-447.73M
-32.06%-415.33M
-32.06%-415.33M
-33.41%-383.04M
-42.60%-372.79M
-47.07%-343.17M
-51.93%-314.49M
-51.93%-314.49M
Paid-in capital
51.37%1.08B
53.57%1.07B
86.53%1.05B
32.20%723.14M
32.20%723.14M
31.83%712.44M
30.20%697.58M
5.88%562.05M
3.89%547.02M
3.89%547.02M
Gains losses not affecting retained earnings
102.06%1.08M
-184.93%-293K
59.63%-109K
101.34%16K
101.34%16K
128.85%534K
118.88%345K
81.00%-270K
-182.74%-1.2M
-182.74%-1.2M
Total stockholders'equity
67.59%552.95M
80.95%588.34M
174.72%600.56M
33.07%307.83M
33.07%307.83M
31.22%329.93M
19.31%325.14M
-26.16%218.61M
-27.50%231.34M
-27.50%231.34M
Total equity
67.59%552.95M
80.95%588.34M
174.72%600.56M
33.07%307.83M
33.07%307.83M
31.22%329.93M
19.31%325.14M
-26.16%218.61M
-27.50%231.34M
-27.50%231.34M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 57.01%501.89M74.63%541.95M162.36%525.91M34.97%288.23M34.97%288.23M40.38%319.66M28.73%310.34M-15.12%200.45M-13.81%213.55M-13.81%213.55M
-Cash and cash equivalents -31.97%187.54M-19.99%189.06M250.77%275.59M375.84%249.11M375.84%249.11M154.56%275.68M108.23%236.31M3.42%78.57M-65.78%52.35M-65.78%52.35M
-Short-term investments 614.67%314.35M376.67%352.89M105.37%250.32M-75.73%39.12M-75.73%39.12M-63.17%43.99M-41.98%74.03M-23.91%121.89M70.09%161.2M70.09%161.2M
Other current assets 3.33%8.87M43.78%10.69M46.95%9.68M20.11%8.36M20.11%8.36M--8.58M--7.43M--6.59M-17.73%6.96M-17.73%6.96M
Total current assets 55.60%510.76M73.91%552.63M158.69%535.59M34.50%296.59M34.50%296.59M41.19%328.24M28.90%317.78M-14.81%207.04M-13.96%220.51M-13.96%220.51M
Non current assets
Net PPE 27.35%41.63M-12.48%29.45M-10.88%30.58M-10.42%31.67M-10.42%31.67M-7.95%32.69M-3.64%33.65M5.13%34.32M22.08%35.35M22.08%35.35M
-Gross PPE 31.25%57.12M0.61%43.75M1.43%43.69M1.21%43.6M1.21%43.6M3.06%43.52M5.76%43.48M12.24%43.07M25.66%43.08M25.66%43.08M
-Accumulated depreciation -43.02%-15.49M-45.38%-14.3M-49.68%-13.11M-54.40%-11.93M-54.40%-11.93M-61.32%-10.83M-58.72%-9.84M-52.76%-8.76M-45.13%-7.73M-45.13%-7.73M
Investments and advances --48.78M--35.72M4,379.86%62.94M123.19%10.95M123.19%10.95M--0--0-97.09%1.41M-92.75%4.91M-92.75%4.91M
Other non current assets 319.94%2.86M114.81%2.32M-38.81%771K-36.67%684K-36.67%684K-35.23%682K12.15%1.08M44.00%1.26M79.40%1.08M79.40%1.08M
Total non current assets 179.51%93.27M94.33%67.48M154.98%94.3M4.76%43.3M4.76%43.3M-30.02%33.37M-38.44%34.73M-54.83%36.98M-57.48%41.34M-57.48%41.34M
Total assets 67.04%604.03M75.92%620.12M158.13%629.88M29.81%339.89M29.81%339.89M29.07%361.61M16.36%352.5M-24.90%244.02M-25.92%261.85M-25.92%261.85M
Liabilities
Current liabilities
Payables -37.96%2.92M-1.77%3.43M75.12%4.22M5.81%3.52M5.81%3.52M218.45%4.71M5.34%3.49M-10.18%2.41M-30.27%3.32M-30.27%3.32M
-accounts payable -37.96%2.92M-1.77%3.43M75.12%4.22M5.81%3.52M5.81%3.52M218.45%4.71M5.34%3.49M-10.18%2.41M-30.27%3.32M-30.27%3.32M
Current accrued expenses 110.07%21.42M94.25%12.78M66.48%9.01M35.45%12.01M35.45%12.01M40.72%10.19M6.72%6.58M2.85%5.41M14.54%8.87M14.54%8.87M
Current debt and capital lease obligation 62.86%5.09M3.00%3.2M18.48%3.17M18.61%3.15M18.61%3.15M18.72%3.13M19.53%3.1M31.47%2.68M115.68%2.66M115.68%2.66M
-Current capital lease obligation 62.86%5.09M3.00%3.2M18.48%3.17M18.61%3.15M18.61%3.15M18.72%3.13M19.53%3.1M31.47%2.68M115.68%2.66M115.68%2.66M
Current deferred liabilities -73.08%35K--0--0-69.12%273K-69.12%273K-94.11%130K-74.47%576K-63.11%778K-65.99%884K-65.99%884K
Current liabilities 62.23%29.47M41.12%19.4M45.44%16.4M20.47%18.95M20.47%18.95M33.91%18.16M-4.06%13.75M-6.72%11.28M-3.72%15.73M-3.72%15.73M
Non current liabilities
Long term debt and capital lease obligation 64.10%19.74M-16.50%10.46M-15.43%11M-14.46%11.52M-14.46%11.52M-13.56%12.03M-13.02%12.53M-12.02%13.01M-11.49%13.47M-11.49%13.47M
-Long term capital lease obligation 64.10%19.74M-16.50%10.46M-15.43%11M-14.46%11.52M-14.46%11.52M-13.56%12.03M-13.02%12.53M-12.02%13.01M-11.49%13.47M-11.49%13.47M
Non current deferred liabilities 16.79%1.28M55.61%1.32M49.55%1.32M-9.67%972K-9.67%972K9.49%1.1M-41.67%847K-49.80%884K-56.80%1.08M-56.80%1.08M
Derivative product liabilities 7.32%396K80.19%382K68.49%369K74.06%369K74.06%369K73.24%369K-4.50%212K-0.90%219K-0.93%212K-0.93%212K
Other non current liabilities 880.00%196K791.67%214K696.55%231K1,080.95%248K1,080.95%248K-13.04%20K100.00%24K93.33%29K-82.50%21K-82.50%21K
Total non current liabilities 59.92%21.62M-9.08%12.37M-8.61%12.92M-11.28%13.11M-11.28%13.11M-10.82%13.52M-15.40%13.61M-15.75%14.14M-18.09%14.78M-18.09%14.78M
Total liabilities 61.24%51.08M16.15%31.78M15.38%29.32M5.09%32.06M5.09%32.06M10.30%31.68M-10.06%27.36M-11.97%25.42M-11.26%30.51M-11.26%30.51M
Shareholders'equity
Share capital 25.00%5K25.00%5K66.67%5K33.33%4K33.33%4K33.33%4K33.33%4K0.00%3K0.00%3K0.00%3K
-common stock 25.00%5K25.00%5K66.67%5K33.33%4K33.33%4K33.33%4K33.33%4K0.00%3K0.00%3K0.00%3K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -37.46%-526.52M-29.48%-482.68M-30.47%-447.73M-32.06%-415.33M-32.06%-415.33M-33.41%-383.04M-42.60%-372.79M-47.07%-343.17M-51.93%-314.49M-51.93%-314.49M
Paid-in capital 51.37%1.08B53.57%1.07B86.53%1.05B32.20%723.14M32.20%723.14M31.83%712.44M30.20%697.58M5.88%562.05M3.89%547.02M3.89%547.02M
Gains losses not affecting retained earnings 102.06%1.08M-184.93%-293K59.63%-109K101.34%16K101.34%16K128.85%534K118.88%345K81.00%-270K-182.74%-1.2M-182.74%-1.2M
Total stockholders'equity 67.59%552.95M80.95%588.34M174.72%600.56M33.07%307.83M33.07%307.83M31.22%329.93M19.31%325.14M-26.16%218.61M-27.50%231.34M-27.50%231.34M
Total equity 67.59%552.95M80.95%588.34M174.72%600.56M33.07%307.83M33.07%307.83M31.22%329.93M19.31%325.14M-26.16%218.61M-27.50%231.34M-27.50%231.34M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data